Authors: Ohyashiki, K Nishimaki, J Shoji, N Miyazawa, K Kimura, Y Ohyashiki, JH

Citation: K. Ohyashiki et al., Re-evaluation of refractory anemia with excess blasts in transformation, LEUK RES, 25(11), 2001, pp. 933-939

Authors: Katagiri, T Miyazawa, K Nishimaki, J Yaguchi, M Kawanishi, Y Ohyashiki, K

Citation: T. Katagiri et al., Combination of granulocyte colony-stimulating factor and low-dose cytosinearabinoside further enhances myeloid differentiation in leukemia cells in vitro, LEUK LYMPH, 39(1-2), 2000, pp. 173-184

Authors: Miyazawa, K Nishimaki, J Ohyashiki, K Enomoto, S Kuriya, S Fukuda, R Hotta, T Teramura, M Mizoguchi, H Uchiyama, T Omine, M

Citation: K. Miyazawa et al., Vitamin K-2 therapy for myelodysplastic syndromes (MDS) and post-MDS acutemyeloid leukemia: information through a questionnaire survey of multi-center pilot studies in Japan, LEUKEMIA, 14(6), 2000, pp. 1156-1157

Authors: Nishimaki, J Miyazawa, K Yaguchi, M Katagiri, T Kawanishi, Y Toyama, K Ohyashiki, K Hashimoto, S Nakaya, K Takiguchi, T

Citation: J. Nishimaki et al., Vitamin K-2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation, LEUKEMIA, 13(9), 1999, pp. 1399-1405